Westlake Chemical Partners LP
WLKP
$23.07
-$0.13-0.56%
NYSE
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 290.06M | 277.00M | 284.17M | 284.67M | 297.27M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 290.06M | 277.00M | 284.17M | 284.67M | 297.27M |
Cost of Revenue | 185.25M | 166.27M | 182.94M | 182.49M | 196.59M |
Gross Profit | 104.81M | 110.72M | 101.23M | 102.18M | 100.68M |
SG&A Expenses | 6.56M | 7.25M | 7.61M | 7.08M | 7.87M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 191.81M | 173.53M | 190.54M | 189.57M | 204.46M |
Operating Income | 98.25M | 103.47M | 93.63M | 95.10M | 92.82M |
Income Before Tax | 87.59M | 104.32M | 88.23M | 89.86M | 87.26M |
Income Tax Expenses | 202.00K | 216.00K | 207.00K | 210.00K | 206.00K |
Earnings from Continuing Operations | 87.39M | 104.10M | 88.03M | 89.65M | 87.06M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -72.39M | -85.96M | -73.60M | -74.81M | -72.76M |
Net Income | 15.00M | 18.14M | 14.43M | 14.83M | 14.30M |
EBIT | 98.25M | 103.47M | 93.63M | 95.10M | 92.82M |
EBITDA | 125.73M | 131.58M | 121.94M | 123.10M | 121.12M |
EPS Basic | 0.43 | 0.51 | 0.41 | 0.42 | 0.41 |
Normalized Basic EPS | -0.39 | -0.70 | -0.52 | -0.53 | -0.52 |
EPS Diluted | 0.43 | 0.51 | 0.41 | 0.42 | 0.41 |
Normalized Diluted EPS | -0.39 | -0.70 | -0.52 | -0.53 | -0.52 |
Average Basic Shares Outstanding | 34.87M | 35.24M | 35.23M | 35.23M | 34.88M |
Average Diluted Shares Outstanding | 34.87M | 35.24M | 35.23M | 35.23M | 34.88M |
Dividend Per Share | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Payout Ratio | 110.77% | 91.59% | 115.11% | 111.96% | 116.14% |